Patient Care

Hand Hygiene Improves Patient Safety


Clinical Question: Does improving hand hygiene compliance from a high level (>80%) to a very high level (>95%) reduce healthcare-associated infections?

Background: Hand hygiene compliance remains an elusive infection prevention parameter to master. Studies show a correlation in reduction of healthcare-associated infections with improved hand hygiene compliance from a low to medium level, but little data exist on very high rates of hand hygiene compliance.

Study Design: Prospective observational.

Setting: University of North Carolina Hospitals.

Synopsis: Researchers recruited all hospital staff to be hand hygiene monitors, thereby using the Hawthorne effect to drive hand hygiene compliance rates. Over a 17-month period, >4,000 unique observers made >140,000 observations. Data showed a significant increase in hand hygiene compliance rates of about 10% (P<0.001) and a significant decrease in overall healthcare-associated infection rates of about 6% (P=0.0066). A reduction in healthcare-associated Clostridium difficile infection of 14% was observed in association with the improved hand hygiene compliance. No association with multidrug-resistant organisms was found.

Bottom Line: There is continued correlation between improved hand hygiene compliance and reduced healthcare-associated infection rates even at very high levels (>95%) of hand hygiene compliance.

Citation: Sickbert-Bennett EE, DiBiase LM, Willis TM, Wolak ES, Weber DJ, Rutala WA. Reduction of healthcare-associated infections by exceeding high compliance with hand hygiene practices. Emerg Infect Dis. 2016;22(9):1628-1630.

Short Take

Avoid Fluoroquinolones in Acute Sinusitis, Acute Exacerbations of Bronchitis, and Uncomplicated Urinary Tract Infections If Other Treatment Options Exist

Because fluoroquinolones have been associated with potentially permanent side effects involving tendons, muscles, joints, and nerves, the FDA recently updated the boxed warning to state that the risk of use likely outweighs the benefit for uncomplicated infections.

Citation: Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects. FDA website. Accessed September 9, 2016.

Recommended Reading

Traditional Hand Hygiene Audits Can Lead to Inaccurate Conclusions about Physician Performance
The Hospitalist
Improving the Care of Patients with COPD
The Hospitalist
SHM Rolls Out New Structure for Leadership Academy 2017
The Hospitalist
Hospitalists Need to Rethink the Way They Evaluate Students
The Hospitalist
Long-Term Mortality in Nondiabetic Patients Favors Coronary Artery Bypass Over Intervention with Drug-Eluting Stents
The Hospitalist
Prolonged Ceftaroline Exposure Associated with High Incidence of Neutropenia
The Hospitalist
Measuring Excellent Comportment among Hospitalists
The Hospitalist
Improving Hospital Telemetry Usage
The Hospitalist
Dr. Hospitalist: Visa Problems Must Be Addressed
The Hospitalist
Use Whiteboards to Enhance Patient-Provider Communication
The Hospitalist
   Comments ()